Solute Carrier Transporters Gain Attention as Potential Targets for CNS Disorder Treatments
New research highlights solute carrier (SLC) membrane transporters as promising targets for treating central nervous system disorders such as epilepsy, neurodegeneration, and autism spectrum disorders.